Related Experiment Videos
Synovial sarcoma of the neck
D C Doval1, V Kannan, G Mukherjee
1Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, India.
Summary
Primary synovial sarcoma is a rare head and neck tumor. Multimodal therapy including surgery, radiotherapy, and chemotherapy achieved successful locoregional control in most patients.
Area of Science:
- Oncology
- Surgical Pathology
- Head and Neck Surgery
Background:
- Primary synovial sarcoma is an uncommon malignancy.
- These tumors rarely occur in the head and neck region.
- Limited data exists on the management and outcomes of head and neck synovial sarcomas.
Purpose of the Study:
- To review seven cases of primary synovial sarcoma in the head and neck.
- To analyze clinical presentations, radiological findings, histopathology, and management strategies.
- To evaluate the efficacy of multimodal therapy for these rare tumors.
Main Methods:
- Case series review of seven patients with primary synovial sarcoma of the head and neck.
- Detailed analysis of clinical, radiological, and histopathological data.
- Evaluation of treatment outcomes following multimodal therapy (surgery, radiotherapy, chemotherapy).
Main Results:
- Seven cases were identified in various head and neck locations (parapharyngeal, supraclavicular, hypopharynx, sternocleidomastoid, submandibular).
- All patients underwent aggressive multimodal therapy.
- Five patients achieved disease-free survival ranging from 24 to 108 months.
Conclusions:
- Aggressive multimodal therapy is crucial for managing primary synovial sarcoma of the head and neck.
- Achieving locoregional control is the key indicator of successful treatment.
- Further research is warranted to optimize treatment protocols for this rare entity.